Prodia Stem Cell Indonesia

PT Prodia Stem Cell Indonesia, commonly known as ProSTEM, is a leading Indonesian biotechnology company specializing in regenerative medicine and stem cell services. Established in 2013 as part of the Prodia Group, the company provides a comprehensive suite of services including cord blood and umbilical cord tissue banking, as well as the manufacturing of Mesenchymal Stem Cells (MSCs). ProSTEM operates a state-of-the-art laboratory facility that is licensed by the Indonesian Ministry of Health and adheres to international Good Manufacturing Practice (GMP) standards. The company is actively involved in clinical research, collaborating with hospitals and academic institutions to develop cell-based therapies for conditions such as osteoarthritis, diabetes, and cardiovascular diseases. By integrating advanced processing technologies with rigorous quality control, ProSTEM aims to be a center of excellence for regenerative medicine in Southeast Asia.